Health
COVID-19 rapid antibody test receives CE mark and mass production begins – News-Medical.Net
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium, has received its CE mark. This means it is approved for professional use in the UK and EU.
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark. This means it is approved for professional use in the UK and EU.
This milestone means the rapid test, for detection of IgG antibodies to the SARS-CoV-2 virus (COVID-19) is now available for distribution for professional use. It will be mass produced and tests will be rolled out from the end of August. The test can be administere…
-
Business19 hours agoHeres a 5-stock portfolio to consider to aim for $1k a month in passive income
-
Noosa News17 hours agoQueensland passes laws restricting use of good character references in sentencing convicted sex offenders
-
Noosa News18 hours agoImmigration needs to be managed, says MP Llew O’Brien
-
General20 hours agoAustralia set to unveil contested 2035 climate target